We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 74

FDA Public Meeting on Tobacco Product Application Review
  • Troutman Sanders LLP
  • USA
  • October 18 2018

On October 22-23, 2018, the Food and Drug Administration will hold a public meeting on the tobacco product application review process. More


FDA Submits Expedited Timeline for Graphic Health Warnings Rule
  • Troutman Sanders LLP
  • USA
  • October 9 2018

The FDA has submitted a proposed, expedited schedule for the issuance of a final graphic warnings rule for cigarettes. Last month, Judge Indira


FDA Secures Additional Time to Submit Court-Compelled Expedited Schedule for a Final Graphic Health Warnings Rule
  • Troutman Sanders LLP
  • USA
  • September 28 2018

As a follow-up to our earlier blog post on this topic, the FDA now has until October 5, 2018 to provide an expedited schedule for the issuance of a


Data Privacy: The Current Landscape
  • Troutman Sanders LLP
  • USA
  • September 27 2018

Since 1997 (the year the European Union adopted Article 29), a debate has raged over which side of the pond has the better approach to privacy


Federal Court Forces FDA’s Hand on Graphic Warning Labels
  • Troutman Sanders LLP
  • USA
  • September 7 2018

This week, in a rare instance of a court directing a federal agency to take action, the U.S. District Court for the District of Massachusetts ordered


Louisiana Broadens Vapor Laws’ Reach to Include Non-Nicotine Products
  • Troutman Sanders LLP
  • USA
  • September 4 2018

Louisiana has redefined “vapor products” to include nicotine and non-nicotine products. The law became effective on May 30, 2018 when Governor John


FDA Announces its Plans to Issue Tobacco Product Application “Foundational” Rules
  • Troutman Sanders LLP
  • USA
  • August 27 2018

To mark the nine-year anniversary of the Family Smoking Prevention and Tobacco Control Act and the one-year anniversary of FDA’s Comprehensive Plan


Democrat Senators Seek Amendment of FCRA, FDCPA for Medical Debts
  • Troutman Sanders LLP
  • USA
  • August 21 2018

On August 16, seven Democrat senators proposed a bill (S.3351, named the “Medical Debt Relief Act of 2018”) to amend the Fair Credit Reporting Act and


State Attorneys General, U.S. Senators Seek to Ban All Flavored Tobacco Products
  • Troutman Sanders LLP
  • USA
  • August 20 2018

In connection with the FDA’s Advanced Notice of Proposed Rulemaking (“ANPR”) addressing flavored tobacco products, a group of State Attorneys General


Deeming Regulations Litigation Update-U.S. District Court for the District of Columbia Expected Forum for Three Appointments Clause Challenges
  • Troutman Sanders LLP
  • USA
  • July 30 2018

The FDA has advanced in its “procedural maneuvering” in three constitutional challenges to the Deeming Regulations. The challenges - premised on the